Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656
- 21 May 2007
- journal article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 28 (2), 104-111
- https://doi.org/10.1002/jat.1252
Abstract
A number of clinically used drugs block delayed rectifier K+ channels and prolong the duration of cardiac action potentials associated with long QT syndrome. This study investigated the molecular mechanisms of voltage‐dependent inhibition of human ether‐a‐go‐go‐related gene (HERG) delayed rectifier K+ channels expressed in HEK‐293 cells by brompheniramine, an antihistamine. Brompheniramine inhibited HERG current in a concentration‐dependent manner with the half‐maximal inhibitory concentration (IC50) value of 1.7 µm at 0 mV. A block of HERG current by brompheniramine was enhanced by progressive membrane depolarization and showed significantly negative shift in voltage‐dependence of channel activation. Inhibition of HERG current by brompheniramine showed time‐dependence. The S6 residue HERG mutant Y652A and F656C largely reduced the blocking potency of HERG current. These results indicate that brompheniramine mainly inhibited the HERG potassium channel through the residue Y652 and F656 and these residues may be an obligatory determinant in inhibition of HERG current for brompheniramine. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channelJournal of Molecular and Cellular Cardiology, 2006
- Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic DrugsJournal of Pharmacology and Experimental Therapeutics, 2005
- Lidoflazine is a high affinity blocker of the HERG K+channelJournal of Molecular and Cellular Cardiology, 2004
- Physicochemical Features of the hERG Channel Drug Binding SitePublished by Elsevier BV ,2004
- Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652British Journal of Pharmacology, 2003
- The impact of drug-induced QT interval prolongation on drug discovery and developmentNature Reviews Drug Discovery, 2003
- Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel BlockPublished by Elsevier BV ,2002
- Open Channel Block of HERG K+ Channels by VesnarinoneMolecular Pharmacology, 2001
- A structural basis for drug-induced long QT syndromeProceedings of the National Academy of Sciences of the United States of America, 2000
- Blocker protection in the pore of a voltage-gated K+ channel and its structural implicationsNature, 2000